CD8+ T cells mediate antibody-independent platelet clearance in mice

Blood

Volumn 127, Issue 14, 2016, Pages 1823-1827

  Arthur, Connie M ^a   Patel, Seema R ^a   Sullivan, H Cliff ^a   Winkler, Annie M ^a   Tormey, Chris A ^b   Hendrickson, Jeanne E ^b   Stowell, Sean R ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD8+ T LYMPHOCYTE; CLEARANCE; CONTROLLED STUDY; IMMUNE RESPONSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; THROMBOCYTE; THROMBOCYTE TRANSFUSION; ANIMAL; HUMAN; IMMUNOLOGY; PATHOLOGY;

ANIMALS; BLOOD PLATELETS; CD8-POSITIVE T-LYMPHOCYTES; HUMANS; ISOANTIBODIES; MICE; PLATELET TRANSFUSION;

EID: 85016923807     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2015-10-673426     Document Type: Article

References (26)

1. Stroncek DF, Rebulla P. Platelet transfusions. Lancet. 2007;370(9585):427-438.
2. The Trial to Reduce Alloimmunization to Platelets Study Group. Leukocyte reduction and ultraviolet B irradiation of platelets to prevent alloimmunization and refractoriness to platelet transfusions. N Engl J Med. 1997;337(26):1861-1869.
3. Jackman RP, Deng X, Bolgiano D, et al. Low-level HLA antibodies do not predict platelet transfusion failure in TRAP study participants. Blood. 2013;121(16):3261-3266, quiz 3299.
4. Bougie DW, Nayak D, Boylan B, Newman PJ, Aster RH. Drug-dependent clearance of human platelets in the NOD/scid mouse by antibodies from patients with drug-induced immune thrombocytopenia. Blood. 2010;116(16):3033-3038.
5. Yankee RA, Grumet FC, Rogentine GN. Platelet transfusion the selection of compatible platelet donors for refractory patients by lymphocyte HL-A typing. N Engl J Med. 1969;281(22):1208-1212.
6. Yankee RA, Graff KS, Dowling R, Henderson ES. Selection of unrelated compatible platelet donors by lymphocyte HL-A matching. N Engl J Med. 1973;288(15):760-764.
7. McElligott MC, Menitove JE, Duquesnoy RJ, Hunter JB, Aster RH. Effect of HLA Bw4/Bw6 compatibility on platelet transfusion responses of refractory thrombocytopenic patients. Blood. 1982;59(5):971-975.
8. Bakchoul T, Boylan B, Sachs UJ, et al. Blockade of maternal anti-HPA-1a-mediated platelet clearance by an HPA-1a epitope-specific F(ab') in an in vivo mouse model of alloimmune thrombocytopenia. Transfusion. 2009;49(2):265-270.
9. Patel SR, Cadwell CM, Medford A, Zimring JC. Transfusion of minor histocompatibility antigen-mismatched platelets induces rejection of bone marrow transplants in mice. J Clin Invest. 2009;119(9):2787-2794.
10. Slichter SJ, Deeg HJ, Kennedy MS. Prevention of platelet alloimmunization in dogs with systemic cyclosporine and by UV-irradiation or cyclosporine-loading of donor platelets. Blood. 1987;69(2):414-418.
11. Semple JW, Speck ER, Milev YP, Blanchette V, Freedman J. Indirect allorecognition of platelets by T helper cells during platelet transfusions correlates with anti-major histocompatibility complex antibody and cytotoxic T lymphocyte formation. Blood. 1995;86(2):805-812.
12. Semple JW, Speck ER, Cosgrave D, Lazarus AH, Blanchette VS, Freedman J. Extreme leukoreduction of major histocompatibility complex class II positive B cells enhances allogeneic platelet immunity. Blood. 1999;93(2):713-720.
13. Bang KW, Speck ER, Blanchette VS, Freedman J, Semple JW. Unique processing pathways within recipient antigen-presenting cells determine IgG immunity against donor platelet MHC antigens. Blood. 2000;95(5):1735-1742.
14. Sayeh E, Sterling K, Speck E, Freedman J, Semple JW. IgG antiplatelet immunity is dependent on an early innate natural killer cell-derived interferon-gamma response that is regulated by CD8+ T cells. Blood. 2004;103(7):2705-2709.
15. Maugeri N, Rovere-Querini P, Evangelista V, et al. Neutrophils phagocytose activated platelets in vivo: a phosphatidylserine, P-selectin, and beta2 integrin-dependent cell clearance program. Blood. 2009;113(21):5254-5265.
16. Savage B, Almus-Jacobs F, Ruggeri ZM. Specific synergy of multiple substrate-receptor interactions in platelet thrombus formation under flow. Cell. 1998;94(5):657-666.
17. Ruggeri ZM, Dent JA, Saldívar E. Contribution of distinct adhesive interactions to platelet aggregation in flowing blood. Blood. 1999;94(1):172-178.
18. Denis C, Methia N, Frenette PS, et al. A mouse model of severe von Willebrand disease: defects in hemostasis and thrombosis. Proc Natl Acad Sci USA. 1998;95(16):9524-9529.
19. Dominici M, Tadjali M, Kepes S, et al. Transgenic mice with pancellular enhanced green fluorescent protein expression in primitive hematopoietic cells and all blood cell progeny. Genesis. 2005;42(1):17-22.
20. Olsson B, Andersson PO, Jernås M, et al. T-cell-mediated cytotoxicity toward platelets in chronic idiopathic thrombocytopenic purpura. Nat Med. 2003;9(9):1123-1124.
21. Halamay KE, Kirkman RL, Sun L, et al. CD8 T cells are sufficient to mediate allorecognition and allograft rejection. Cell Immunol. 2002;216(1-2):6-14.
22. Kitamura D, Roes J, Kühn R, Rajewsky K. A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin mu chain gene. Nature. 1991;350(6317):423-426.
23. Slichter SJ, Davis K, Enright H, et al. Factors affecting posttransfusion platelet increments, platelet refractoriness, and platelet transfusion intervals in thrombocytopenic patients. Blood. 2005;105(10):4106-4114.
24. Toor AA, Choo SY, Little JA. Bleeding risk and platelet transfusion refractoriness in patients with acute myelogenous leukemia who undergo autologous stem cell transplantation. Bone Marrow Transplant. 2000;26(3):315-320.
25. McMillan R. The pathogenesis of chronic immune thrombocytopenic purpura. Semin Hematol. 2007;44(4 suppl 5):S3-S11.
26. Heal JM, Blumberg N, Masel D. An evaluation of crossmatching, HLA, and ABO matching for platelet transfusions to refractory patients. Blood. 1987;70(1):23-30.